R.J. Hedges Blog

Follow-Up Update: CDC Clarifies 2026-2027 COVID-19 Vaccination Recommendations

becky@rjhedges.com (Becky Templeton) — Fri, 02 Oct 2026 16:56:40 GMT

We are writing to provide an important update to our August 20 and September 2, 2026 communications regarding federal vaccine recommendations and their potential impact on pharmacy vaccine administration authority, standing orders, and protocols.

Update: CDC Issues Interim Guidance for 2026-2027 Influenza Vaccination Season

becky@rjhedges.com (Becky Templeton) — Thu, 03 Sep 2026 18:35:02 GMT

We are writing to provide an important update to our August 28, 2026 communication regarding ongoing uncertainty surrounding federal vaccine recommendations and their impact on pharmacy vaccine administration authority, standing orders, and protocols.

Central Fill, GLP-1s, and Peptides: What Independent Pharmacies Need to Know

becky@rjhedges.com (Becky Templeton) — Wed, 02 Sep 2026 13:45:00 GMT

Sterile compounded medications, especially GLP-1 therapies like semaglutide and tirzepatide, have created one of the fastest-growing opportunities independent pharmacy has seen in years. In our latest Partnership Series webinar, Nicolette Mathey, PharmD, of Atrium24 walked our clients through why this market is growing, why so many pharmacies hesitate to get involved, and how to participate without taking on the cost and complexity of building a sterile compounding pharmacy from scratch. Here's a recap of what she covered and you can watch the full webinar recording here.

CDC/ACIP Vaccine Guidance Uncertainty and Impact on Standing Orders

becky@rjhedges.com (Becky Templeton) — Fri, 28 Aug 2026 18:31:20 GMT

***Please note we published an update to this blog on 9/3/26 to view the update please visit https://www.rjhedges.com/blog/update:-cdc-issues-interim-guidance-for-2026-2027-influenza-vaccination-season

We would like to provide an update regarding the ongoing uncertainty surrounding federal vaccine recommendations and explain how these developments may affect annual Influenza, COVID-19 and additional vaccine standing orders, protocols, and pharmacist vaccination authority in your state.

R.J. Hedges & Associates and Atrium24 Partner

becky@rjhedges.com (Becky Templeton) — Thu, 20 Aug 2026 19:16:21 GMT

FOR IMMEDIATE RELEASE

Medical Billing for Independent Pharmacies: Are You Leaving Revenue on the Table?

becky@rjhedges.com (Becky Templeton) — Thu, 16 Jul 2026 21:08:42 GMT

Partnership Series

At R.J. Hedges & Associates, we believe some of the best ideas come from bringing together trusted experts who share a common goal: helping independent pharmacies thrive. That's the purpose behind our Partnership Series, where we collaborate with industry leaders to provide practical, educational content on today's most important pharmacy topics. In our latest webinar, we welcomed DocStation, a pharmacy-focused medical billing platform, to discuss how pharmacies can identify overlooked reimbursement opportunities while expanding clinical services and enhancing patient care.

DEA Increasing Scrutiny on Pharmacy Applications & Change of Ownership

becky@rjhedges.com (Becky Templeton) — Fri, 15 May 2026 13:15:00 GMT

R.J. Hedges & Associates named to Pharmacy500

becky@rjhedges.com (Becky Templeton) — Wed, 06 May 2026 13:30:00 GMT

R.J. Hedges & Associates is proud to share that we have been recognized in the 2026 Pharmacy500, presented by RXinsider.

The Pharmacy500 highlights 500 pharmacy supply chain businesses and associations that have made a meaningful impact on dispensing pharmacies across the United States over the past year. The recognition reflects organizations that actively support pharmacy operations, patient care, and the evolving needs of the industry.

We are honored to be included alongside so many outstanding companies and individuals who are dedicated to strengthening and supporting independent pharmacy.

For more than 20 years, R.J. Hedges & Associates has focused on helping independent pharmacies navigate the complexities of regulatory compliance. From ever-changing federal requirements to accreditation and operational readiness, our goal has always been to provide clear, practical guidance that allows pharmacy teams to focus on what matters most - caring for their patients.

“This recognition is especially meaningful because it reflects the impact our staff has on the pharmacies we serve,” said Becky Templeton, Director of Operations at R.J. Hedges & Associates. “We’re grateful for the trust our clients place in us every day and proud to support the important work they do in their communities.”

As the pharmacy landscape continues to evolve, the need for reliable compliance support remains critical. We are proud to stand alongside industry partners who are committed to helping pharmacies adapt, grow, and succeed.

Thank you to RXinsider for this recognition, and congratulations to the other organizations included in the 2026 Pharmacy500.

Most importantly, thank you to our clients; your trust and partnership over the past 20 years are what make recognition like this possible.

R.J. Hedges Continues Strategic Partnership with ACHC

becky@rjhedges.com (Becky Templeton) — Tue, 05 May 2026 12:45:00 GMT

FOR IMMEDIATE RELEASE

ACHC Continues Strategic Partnership with R.J. Hedges

R.J. Hedges Partnership with DocStation

becky@rjhedges.com (Becky Templeton) — Fri, 01 May 2026 19:59:22 GMT

FOR IMMEDIATE RELEASE

DocStation and R.J. Hedges & Associates Announce Collaboration to Support Independent Pharmacies Billing Medicare